Bi­par­ti­san House bill seeks new $30B ‘BioBonds’ loan pro­gram to rein­vig­o­rate clin­i­cal tri­als

As thou­sands of clin­i­cal tri­als were sus­pend­ed or halt­ed due to the Covid-19 pan­dem­ic over the last year, House mem­bers on both sides of the aisle are try­ing to find new ways to jump­start the clin­i­cal tri­al ecosys­tem.

For those with an IND in hand, and pur­su­ing a drug tar­get­ing an un­met need, Reps. Bob­by Rush (D-IL) and Bri­an Fitz­patrick (R-PA) on Fri­day in­tro­duced a new bill that would pro­vide loans to con­tin­ue such re­search if oth­er fund­ing sources run dry.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER